• レポートコード:GIR-107A12283 • 出版社/出版日:GlobalInfoResearch / 2021年7月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、102ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医療 |
Single User | ¥501,120 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥751,680 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,002,240 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、胃不全麻痺治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。胃不全麻痺治療の種類別市場規模(薬物治療、外科的治療)、用途別市場規模(病院、外来手術センター、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・胃不全麻痺治療の市場概要 ・企業情報(企業概要、製品概要、販売量、価格、売上):Medtronic、Abbott、Bausch Health、Boston Scientific、C.R. Bard、Johnson & Johnson、Cardinal Health、Evoke Pharma、Rhythm Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年:薬物治療、外科的治療 ・用途別分析2016年-2026年:病院、外来手術センター、その他 ・胃不全麻痺治療の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ ・胃不全麻痺治療のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア ・胃不全麻痺治療のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア ・胃不全麻痺治療の南米市場規模2016年-2026年:ブラジル、アルゼンチン ・胃不全麻痺治療の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Gastroparesis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gastroparesis Treatment size is estimated to be USD 4264.4 million in 2026 from USD 3923.4 million in 2020, with a change XX% between 2020 and 2021. The global Gastroparesis Treatment market size is expected to grow at a CAGR of 2.1% for the next five years.
Market segmentation
Gastroparesis Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Drug Treatment
Surgical Treatment
Market segment by Application, can be divided into
Hospital
Ambulatory Surgical Center
Others
Market segment by players, this report covers
Medtronic
Abbott
Bausch Health
Boston Scientific
C.R. Bard
Johnson & Johnson
Cardinal Health
Evoke Pharma
Rhythm Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Gastroparesis Treatment
1.2 Classification of Gastroparesis Treatment by Type
1.2.1 Overview: Global Gastroparesis Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Gastroparesis Treatment Revenue Market Share by Type in 2020
1.2.3 Drug Treatment
1.2.4 Surgical Treatment
1.3 Global Gastroparesis Treatment Market by Application
1.3.1 Overview: Global Gastroparesis Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Global Gastroparesis Treatment Market Size & Forecast
1.5 Global Gastroparesis Treatment Market Size and Forecast by Region
1.5.1 Global Gastroparesis Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Gastroparesis Treatment Market Size by Region, (2016-2021)
1.5.3 North America Gastroparesis Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Gastroparesis Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Gastroparesis Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Gastroparesis Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Gastroparesis Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gastroparesis Treatment Market Drivers
1.6.2 Gastroparesis Treatment Market Restraints
1.6.3 Gastroparesis Treatment Trends Analysis
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Gastroparesis Treatment Product and Solutions
2.1.4 Medtronic Gastroparesis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Medtronic Recent Developments and Future Plans
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Gastroparesis Treatment Product and Solutions
2.2.4 Abbott Gastroparesis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Abbott Recent Developments and Future Plans
2.3 Bausch Health
2.3.1 Bausch Health Details
2.3.2 Bausch Health Major Business
2.3.3 Bausch Health Gastroparesis Treatment Product and Solutions
2.3.4 Bausch Health Gastroparesis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bausch Health Recent Developments and Future Plans
2.4 Boston Scientific
2.4.1 Boston Scientific Details
2.4.2 Boston Scientific Major Business
2.4.3 Boston Scientific Gastroparesis Treatment Product and Solutions
2.4.4 Boston Scientific Gastroparesis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Boston Scientific Recent Developments and Future Plans
2.5 C.R. Bard
2.5.1 C.R. Bard Details
2.5.2 C.R. Bard Major Business
2.5.3 C.R. Bard Gastroparesis Treatment Product and Solutions
2.5.4 C.R. Bard Gastroparesis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 C.R. Bard Recent Developments and Future Plans
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Gastroparesis Treatment Product and Solutions
2.6.4 Johnson & Johnson Gastroparesis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Johnson & Johnson Recent Developments and Future Plans
2.7 Cardinal Health
2.7.1 Cardinal Health Details
2.7.2 Cardinal Health Major Business
2.7.3 Cardinal Health Gastroparesis Treatment Product and Solutions
2.7.4 Cardinal Health Gastroparesis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Cardinal Health Recent Developments and Future Plans
2.8 Evoke Pharma
2.8.1 Evoke Pharma Details
2.8.2 Evoke Pharma Major Business
2.8.3 Evoke Pharma Gastroparesis Treatment Product and Solutions
2.8.4 Evoke Pharma Gastroparesis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Evoke Pharma Recent Developments and Future Plans
2.9 Rhythm Pharmaceuticals
2.9.1 Rhythm Pharmaceuticals Details
2.9.2 Rhythm Pharmaceuticals Major Business
2.9.3 Rhythm Pharmaceuticals Gastroparesis Treatment Product and Solutions
2.9.4 Rhythm Pharmaceuticals Gastroparesis Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Rhythm Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gastroparesis Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Gastroparesis Treatment Players Market Share
3.2.2 Top 10 Gastroparesis Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Gastroparesis Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gastroparesis Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Gastroparesis Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Gastroparesis Treatment Revenue Market Share by Application (2016-2021)
5.2 Gastroparesis Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Gastroparesis Treatment Revenue by Type (2016-2026)
6.2 North America Gastroparesis Treatment Revenue by Application (2016-2026)
6.3 North America Gastroparesis Treatment Market Size by Country
6.3.1 North America Gastroparesis Treatment Revenue by Country (2016-2026)
6.3.2 United States Gastroparesis Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Gastroparesis Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Gastroparesis Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Gastroparesis Treatment Revenue by Type (2016-2026)
7.2 Europe Gastroparesis Treatment Revenue by Application (2016-2026)
7.3 Europe Gastroparesis Treatment Market Size by Country
7.3.1 Europe Gastroparesis Treatment Revenue by Country (2016-2026)
7.3.2 Germany Gastroparesis Treatment Market Size and Forecast (2016-2026)
7.3.3 France Gastroparesis Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Gastroparesis Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Gastroparesis Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Gastroparesis Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gastroparesis Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Gastroparesis Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Gastroparesis Treatment Market Size by Region
8.3.1 Asia-Pacific Gastroparesis Treatment Revenue by Region (2016-2026)
8.3.2 China Gastroparesis Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Gastroparesis Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Gastroparesis Treatment Market Size and Forecast (2016-2026)
8.3.5 India Gastroparesis Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Gastroparesis Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Gastroparesis Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Gastroparesis Treatment Revenue by Type (2016-2026)
9.2 South America Gastroparesis Treatment Revenue by Application (2016-2026)
9.3 South America Gastroparesis Treatment Market Size by Country
9.3.1 South America Gastroparesis Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Gastroparesis Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Gastroparesis Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gastroparesis Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Gastroparesis Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Gastroparesis Treatment Market Size by Country
10.3.1 Middle East & Africa Gastroparesis Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Gastroparesis Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Gastroparesis Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Gastroparesis Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Gastroparesis Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Gastroparesis Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Gastroparesis Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Gastroparesis Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Gastroparesis Treatment Revenue Market Share by Region (2021-2026)
Table 6. Medtronic Corporate Information, Head Office, and Major Competitors
Table 7. Medtronic Major Business
Table 8. Medtronic Gastroparesis Treatment Product and Solutions
Table 9. Medtronic Gastroparesis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Abbott Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Major Business
Table 12. Abbott Gastroparesis Treatment Product and Solutions
Table 13. Abbott Gastroparesis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bausch Health Corporate Information, Head Office, and Major Competitors
Table 15. Bausch Health Major Business
Table 16. Bausch Health Gastroparesis Treatment Product and Solutions
Table 17. Bausch Health Gastroparesis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Boston Scientific Corporate Information, Head Office, and Major Competitors
Table 19. Boston Scientific Major Business
Table 20. Boston Scientific Gastroparesis Treatment Product and Solutions
Table 21. Boston Scientific Gastroparesis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. C.R. Bard Corporate Information, Head Office, and Major Competitors
Table 23. C.R. Bard Major Business
Table 24. C.R. Bard Gastroparesis Treatment Product and Solutions
Table 25. C.R. Bard Gastroparesis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 27. Johnson & Johnson Major Business
Table 28. Johnson & Johnson Gastroparesis Treatment Product and Solutions
Table 29. Johnson & Johnson Gastroparesis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Cardinal Health Corporate Information, Head Office, and Major Competitors
Table 31. Cardinal Health Major Business
Table 32. Cardinal Health Gastroparesis Treatment Product and Solutions
Table 33. Cardinal Health Gastroparesis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Evoke Pharma Corporate Information, Head Office, and Major Competitors
Table 35. Evoke Pharma Major Business
Table 36. Evoke Pharma Gastroparesis Treatment Product and Solutions
Table 37. Evoke Pharma Gastroparesis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Rhythm Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Rhythm Pharmaceuticals Major Business
Table 40. Rhythm Pharmaceuticals Gastroparesis Treatment Product and Solutions
Table 41. Rhythm Pharmaceuticals Gastroparesis Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Gastroparesis Treatment Revenue (USD Million) by Players (2019-2021)
Table 43. Global Gastroparesis Treatment Revenue Share by Players (2019-2021)
Table 44. Breakdown of Gastroparesis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Gastroparesis Treatment Players Head Office, Products and Services Provided
Table 46. Gastroparesis Treatment Mergers & Acquisitions in the Past Five Years
Table 47. Gastroparesis Treatment New Entrants and Expansion Plans
Table 48. Global Gastroparesis Treatment Revenue (USD Million) by Type (2016-2021)
Table 49. Global Gastroparesis Treatment Revenue Share by Type (2016-2021)
Table 50. Global Gastroparesis Treatment Revenue Forecast by Type (2021-2026)
Table 51. Global Gastroparesis Treatment Revenue by Application (2016-2021)
Table 52. Global Gastroparesis Treatment Revenue Forecast by Application (2021-2026)
Table 53. North America Gastroparesis Treatment Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Gastroparesis Treatment Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Gastroparesis Treatment Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Gastroparesis Treatment Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Gastroparesis Treatment Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Gastroparesis Treatment Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Gastroparesis Treatment Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Gastroparesis Treatment Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Gastroparesis Treatment Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Gastroparesis Treatment Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Gastroparesis Treatment Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Gastroparesis Treatment Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Gastroparesis Treatment Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Gastroparesis Treatment Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Gastroparesis Treatment Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Gastroparesis Treatment Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Gastroparesis Treatment Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Gastroparesis Treatment Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Gastroparesis Treatment Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Gastroparesis Treatment Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Gastroparesis Treatment Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Gastroparesis Treatment Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Gastroparesis Treatment Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Gastroparesis Treatment Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Gastroparesis Treatment Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Gastroparesis Treatment Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Gastroparesis Treatment Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Gastroparesis Treatment Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Gastroparesis Treatment Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Gastroparesis Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Gastroparesis Treatment Picture
Figure 2. Global Gastroparesis Treatment Revenue Market Share by Type in 2020
Figure 3. Drug Treatment
Figure 4. Surgical Treatment
Figure 5. Gastroparesis Treatment Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Ambulatory Surgical Center Picture
Figure 8. Others Picture
Figure 9. Global Gastroparesis Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Gastroparesis Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Gastroparesis Treatment Revenue Market Share by Region (2016-2026)
Figure 12. Global Gastroparesis Treatment Revenue Market Share by Region in 2020
Figure 13. North America Gastroparesis Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Gastroparesis Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Gastroparesis Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Gastroparesis Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Gastroparesis Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Gastroparesis Treatment Market Drivers
Figure 19. Gastroparesis Treatment Market Restraints
Figure 20. Gastroparesis Treatment Market Trends
Figure 21. Medtronic Recent Developments and Future Plans
Figure 22. Abbott Recent Developments and Future Plans
Figure 23. Bausch Health Recent Developments and Future Plans
Figure 24. Boston Scientific Recent Developments and Future Plans
Figure 25. C.R. Bard Recent Developments and Future Plans
Figure 26. Johnson & Johnson Recent Developments and Future Plans
Figure 27. Cardinal Health Recent Developments and Future Plans
Figure 28. Evoke Pharma Recent Developments and Future Plans
Figure 29. Rhythm Pharmaceuticals Recent Developments and Future Plans
Figure 30. Global Gastroparesis Treatment Revenue Share by Players in 2020
Figure 31. Gastroparesis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Gastroparesis Treatment Revenue Market Share in 2020
Figure 33. Global Top 10 Players Gastroparesis Treatment Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Gastroparesis Treatment Revenue Share by Type in 2020
Figure 36. Global Gastroparesis Treatment Market Share Forecast by Type (2021-2026)
Figure 37. Global Gastroparesis Treatment Revenue Share by Application in 2020
Figure 38. Global Gastroparesis Treatment Market Share Forecast by Application (2021-2026)
Figure 39. North America Gastroparesis Treatment Sales Market Share by Type (2016-2026)
Figure 40. North America Gastroparesis Treatment Sales Market Share by Application (2016-2026)
Figure 41. North America Gastroparesis Treatment Revenue Market Share by Country (2016-2026)
Figure 42. United States Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Gastroparesis Treatment Sales Market Share by Type (2016-2026)
Figure 46. Europe Gastroparesis Treatment Sales Market Share by Application (2016-2026)
Figure 47. Europe Gastroparesis Treatment Revenue Market Share by Country (2016-2026)
Figure 48. Germany Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Gastroparesis Treatment Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Gastroparesis Treatment Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Gastroparesis Treatment Revenue Market Share by Region (2016-2026)
Figure 56. China Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Gastroparesis Treatment Sales Market Share by Type (2016-2026)
Figure 63. South America Gastroparesis Treatment Sales Market Share by Application (2016-2026)
Figure 64. South America Gastroparesis Treatment Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Gastroparesis Treatment Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Gastroparesis Treatment Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Gastroparesis Treatment Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Gastroparesis Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source